Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Ritlecitinib can help about 14,000 people with severe hair loss.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.

Minoxidil helps hair growth in people with monilethrix without side effects.

The drug combination was safe and showed promise in treating advanced tumors.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Two new compounds were found to effectively reduce hair growth in mice.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.